More states consider dropping GLP-1 weight loss drugs from Medicaid
State News – Washington
Massachusetts and Rhode Island are considering dropping GLP-1 drugs for obesity treatment from their Medicaid programs, continuing a trend of states that have stopped coverage of these expensive medications. Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year. Medicaid programs in California, New Hampshire, […] Continue reading this story from the source →
This news is generated from RSS Feeds. Join today to get your news feed on Nationwide Report®.